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Next-generation sequencing technologies allowed sequencing of
thousands of genomes. However, there are genomic regions that
remain difficult to characterize, including telomeres, centromeres,
and other low-complexity regions, as well as transposable ele-
ments and endogenous viruses. Human herpesvirus 6A and 6B
(HHV-6A and HHV-6B) are closely related viruses that infect most
humans and can integrate their genomes into the telomeres of
infected cells. Integration also occurs in germ cells, meaning that
the virus can be inherited and result in individuals harboring the
virus in every cell of their body. The integrated virus can reactivate
and cause disease in humans. While it is well established that the
virus resides in the telomere region, the integration locus is poorly
defined due to the low sequence complexity (TTAGGG)n of telo-
meres that cannot be easily resolved through sequencing. We
therefore employed genome imaging of the integrated HHV-6A
and HHV-6B genomes using whole-genome optical site mapping
technology. Using this technology, we identified which chromo-
some arm harbors the virus genome and obtained a high-
resolution map of the integration loci of multiple patients. Surpris-
ingly, this revealed long telomere sequences at the virus−subte-
lomere junction that were previously missed using PCR-based
approaches. Contrary to what was previously thought, our tech-
nique revealed that the telomere lengths of chromosomes harbor-
ing the integrated virus genome were comparable to the other
chromosomes. Taken together, our data shed light on the genetic
structure of the HHV-6A and HHV-6B integration locus, demon-
strating the utility of optical mapping for the analysis of genomic
regions that are difficult to sequence.
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Human herpesvirus 6A and 6B (HHV-6A and HHV-6B) areclosely related virus species that infect humans (1). HHV-
6B infects almost all humans within the first years of life and
causes the febrile illness exanthema subitum (2). Infection with
HHV-6A is thought to occur later in life, but the epidemiology of
the virus is poorly characterized. Like all herpesviruses, HHV-
6A and HHV-6B establish latency upon primary infection,
allowing the virus to persist in the host for life. In contrast to
other human herpesviruses, HHV-6A and HHV-6B integrate
their genomes into the telomere region of host chromosomes of
latently infected cells (3–6). The viruses can also heritably inte-
grate into germ cells, resulting in individuals and their offspring
that harbor the virus in every nucleated cell (3, 7–11). This
phenomenon is referred to as inherited chromosomally inte-
grated HHV-6 (iciHHV-6). Importantly, HHV-6 reactivation
from the integrated state is associated with various diseases, in-
cluding graft-versus-host disease, encephalitis, and heart disease
(12–18). More recently, a study indicated that telomeres carrying
integrated HHV-6 are shorter and more unstable (19), which, in
turn, could influence aging and/or diseases of individuals with
iciHHV-6.
It remains unknown whether certain integration events or
iciHHV-6 genomes at specific loci are responsible for, or
contribute directly to, disease in humans. Although we can
identify individuals that harbor iciHHV-6A and iciHHV-6B
through qPCR (20), a major challenge in studying iciHHV-6 is
that we cannot readily examine the integration site with high
resolution. Integration loci of HHV-6A and HHV-6B were first
detected by fluorescent in situ hybridization (FISH) (3), and the
junction has since been sequenced using a PCR-based approach
for three different integrations. Sanger sequencing of these PCR
fragments indicated that the right direct repeat (DR-R) is fused
to the subtelomeres with only a very short stretch of telomere
sequences between the virus and host chromosome (4, 5, 19, 21).
However, FISH is a challenging and laborious technique, of-
fering very low spatial resolution that does not allow us to di-
rectly observe the junction. Although PCR amplification and
Sanger sequencing does offer sequence information, this ap-
proach requires previous knowledge of the chromosomal loca-
tion of the virus genome (19, 22), is prone to amplification
errors, and has not succeeded in determining structures of
junctions. Next-generation sequencing (NGS) using various
platforms has not succeeded in sequencing the junction, as either
the coverage or the read length was not sufficient to resolve the
complex and repetitive nature of the telomere region harboring
the virus genome.
We therefore set out to develop an approach to study the
virus−host junction because understanding its composition is key
to understanding the effect of iciHHV-6 on human biology.
Using a whole-genome optical mapping technology (23, 24), we
were able to generate unbiased, high-resolution maps of HHV-6A
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and HHV-6B integration sites, which allowed the identification of
the chromosomes harboring the integrated HHV-6A and HHV-
6B genome in four different iciHHV-6 patient-derived cell lines.
We also know, from our recent work on the evolutionary history
of the virus, that most known integrations are derived from very
few ancestral genome invasion events (25). This means that, for
every sample we determine the chromosomal location for, this
can be extrapolated to many orthologs without the expense and
effort of further experimental work. Our results conclusively
determine the orientation of the virus genome, as well as the
length of the telomeric virus−chromosome junction and the distal
telomeres on the end of the virus genome. Furthermore, the
ability to determine the chromosomal location of the virus will
be crucial to decipher the role of the integrated virus genome in
human diseases.
Results
Genome Imaging of iciHHV-6. To map the integrated HHV-6A and
HHV-6B genome and overcome the obstacle of repetitive se-
quences at the integration site, we used a genome imaging ap-
proach. High molecular weight DNA was isolated from four
iciHHV-6 patient cell lines and labeled at direct labeling en-
zyme 1 (DLE-1) sites via covalent bonding of fluorophores at
specific interspersed sequences throughout the genome
(Fig. 1A). Labeled DNA was counterstained with a general DNA
fluorescent marker, loaded into a flow cell, and electrophoresed
through nanochannels. Fluorescence from labeled individual
DNA molecules was scanned, resulting in long double-stranded
DNA (dsDNA) maps that were aligned to the GRCh38 human
genome. Based on the predicted DLE-1 fluorophore acceptor
sites in the iciHHV-6 genomes (Fig. 1B), this process allowed the
identification of HHV-6 integration sites at chromosomes 18q,
19q, Xp, and 18p (Fig. 2). The integration in chromosome Xp
(Fig. 2D) represents a report of HHV-6 integration into a sex
chromosome.
To validate our genome imaging approach, we performed
FISH to confirm the location of each integration. We used
probes against HHV-6 as well as chromosome-specific probes to
confirm the integration loci for ici6A-1 and ici6B-1, which were
in 18q and 19q, respectively (Fig. 3A). The size and structure of
the virus-containing chromosomes of ici6B-2 and ici6B-3 were
also consistent with Xp and 18p, respectively (Fig. 3B). The
optical maps also revealed that all virus genomes had integrated
with the DR-R facing toward the centromere.
HHV-6 Integration and Telomere Length. Next, we investigated the
length of the telomeric repeats at the terminal ends of the HHV-
6 genome and the virus−subtelomere junction. To characterize
the subtelomere junction for these samples, we combined the
results of optical mapping with existing NGS sequence data of
the integrated virus (which cannot bridge the junction) and hu-
man genome. Using the median lengths of the individual optical
map molecules, we calculated the size of the virus−host junctions
(Fig. 4). Our data indicate that there are long telomere stretches
of 5.0 kb to 13.3 kb between the subtelomeres and the virus
genome (Fig. 4). For one integration site, the length of the in-
ternal telomere was shorter than the respective chromosome pair
end, suggesting that HHV-6 integrated within the telomere re-
peats (Fig. 5). In the case of the other integration sites, length of
these internal telomeres corresponds to physiologically normal
human telomeres, suggesting that HHV-6 integration occurred
at or near the end of the telomere. Consistently, the internal
telomeres were as long as or even longer than the telomere of
the sister chromosome lacking the virus genome (Fig. 5).
In addition, we assessed the length of the telomeres at the
distal end of the iciHHV-6 genome in our patient cells by
measuring the length of all of the individual molecules that ex-
tend out from the left DR (DR-L) and taking the median length
(Fig. 6). In general, it is challenging to measure telomere length,
due to the repetitive nature of telomeres. Quantification of the
telomeres at the distal end of the virus genome for all iciHHV-6
individuals revealed lengths ranging from 8.9 kb to 14.7 kb
(Fig. 6), consistent with normal human telomeres (26, 27). Taken
together, this approach to virus integration mapping was able
to quantify distal telomere lengths in iciHHV-6 individuals
and showed they have sizes comparable with regular human
telomeres.
Discussion
The HHV-6A and HHV-6B integration mechanism and any
physiological/pathological consequences for iciHHV-6 individ-
uals remains poorly understood (28–30). The ability to accurately
determine the virus’s location in the genome is a crucial first
step toward addressing these open questions. We therefore ap-
plied an unbiased whole-genome optical mapping strategy that
Fig. 1. Mapping iciHHV-6 integrations using genome imaging technology. (A) Simplified overview of the workflow to create whole-genome−length optical
maps from patient cells with iciHHV-6. After alignment of the optical maps to the reference human genome, location, orientation, and information about the
virus−host junction should be revealed. (B) DLE-I fluorophore acceptor sites in the four iciHHV-6 studied. Direct repeats (DR) are annotated as the first and
final 8 kb of HHV-6 sequence for orientation purposes. gDNA: genomic DNA.







































Fig. 2. Genome imaging reveals structure of telomere-integrated iciHHV-6. Optical consensus maps (light blue ruler) were constructed from the scanned
dsDNA molecules and were aligned to human GRCh38 reference genome (orange ruler) with the terminal Ns removed. Shown are the integration sites on an
assembled optical genome map for (A) ici6A-1 at 18q, (B) ici6B-1 at 19q, (C) ici6B-2 at Xp, and (D) ici6B-3 at 18p. Below the consensus maps are the individual
dsDNA molecules that were used to build the map (gray lines). Blue or red marks indicate DLE-I sites (marked with fluorophores in the samples), with the red
marks not matching to the reference genome. Green lines indicate the positions of the iciHHV-6 genomes, and the starts of the telomere repeats in the
GRCh38 annotation are marked with a black line on the orange map. Virus genome size was inferred from the NGS data (45) and is annotated with green
boxes and lines.































produces “fingerprint”-like maps of the human chromosomes to
identify and visualize the entire length of the telomere-
integrated HHV-6, including the virus−subtelomere junction.
This allowed us to identify the chromosomal arm in which the
virus has integrated for each sample, and visually corroborate our
results with FISH. Our data conclusively reveal that, in all samples
studied, the virus is oriented with the DR-R situated at the
virus−chromosome junction, and is consistent with previous data
using a PCR-based approach (4, 5, 19, 21) and the current models
of HHV-6 integration (1, 31). Contrary to previous findings, our
data conclusively show that the virus−subtelomere junctions are
extremely long, ranging from 5.0 kb to 13.3 kb (Fig. 4).
Many recent advances have been made to sequencing technology,
especially in the long-read sequencing domain (third-generation
sequencing). Notable technologies in this field are Oxford Nano-
pore Technology (ONT) and single-molecule real-time sequencing,
which both use single-stranded DNA as a template and detect the
specific bases. While these approaches mark a giant leap forward
for genomics, challenges remain regarding the reproducibility of
read lengths, high error rates, and low coverage (difficulty in
obtaining overlapping sequencing reads). This was exemplified by a
recent study that used ONT to sequence the iciHHV-6−host
junction (32). Although successful, it is important to note that
only two reads were obtained across a relatively small junction of 1.3
kb. Our results here have shown that, even in our small dataset, the
junction region is far longer and that we obtained a much higher
coverage compared to the ONT approach. Therefore, while se-
quencing approaches are a necessary element to the study of HHV-
6 integration, optical mapping offers an additional source of
reliable data.
We recently analyzed the evolutionary history of over
250 HHV-6 and iciHHV-6 sequences (25). Our phylogenetic
reconstruction revealed that nearly 80% of the known iciHHV-6
sequences cluster in a handful of clades that represent single
ancestral integration events, including KY315540, KY290178,
and KY315552. Using optical mapping technology has thus en-
abled us to determine the chromosomal location of many more
iciHHV-6 sequences in a more reliable and less laborious way
than with FISH. Moreover, the technique opens the opportunity
to study the differences between sites of the same ancestral in-
tegration, which may reveal changes to the junction that oc-
curred over time, or as a result of variable environmental/
genetic factors.
This study also demonstrates an extremely useful tool for ex-
amining similarly difficult-to-sequence regions of the genome.
This approach has clear applications for telomere biology and
endogenous viruses, transposable elements, and other low-
complexity regions. These genomic elements/features are not
only difficult to sequence from a biochemical standpoint but are
notorious for being extremely challenging at the genomic as-
sembly stage. We have shown that, although optical mapping
technologies do not reveal the target sequence, we can combine
these results with sequence data to provide a clearer picture than
either approach can offer alone. For instance, the endogenous
retrovirus (ERV) group HERV-K (HML-2) is a human ERV
that is insertionally polymorphic; that is, not all people have the
same insertions in the same loci (33). It has been shown that
certain HML-2 insertions can influence nearby genes, such as the
RASGRF2 involved in dopaminergic activity. People carrying an
HML-2 insertion within an intron of RASGRF2 are significantly
more likely to be intravenous drug users (34). This highlights the
importance of being able to accurately map the location of
neglected genomic elements. Since, like with HHV-6A and
HHV-6B, we know the sequence of the HML-2 insertion, we
could easily identify their optical mapping signature from
these data.
The length of the virus−host junction that we show here
provides important insights into the integration mechanism,
which, thus far, remains poorly understood. The fact that inter-
nal telomeric repeats are much longer than the telomeric repeats
present in the virus genome could indicate that the host telomere
is the main contributor for the sequences in the junction. This
suggests that the virus genome integration occurs either at the
telomere ends or at least quite distant from the subtelomere
(Fig. 4). Another interpretation is that the length of the junction
is a side effect of the mechanism itself, whereby some telomere
lengthening process is involved at the point of genome invasion.
Fig. 3. Mapping iciHHV-6 integration using FISH. B-LCLs from patients
carrying iciHHV-6A and iciHHV-6B were fixed and stained with FISH probes
against the HHV-6 genome (red) with or without an additional probe
against a specific human chromosome (green). (A) One iciHHV-6A and one
iciHHV-6B integration that were mapped using dual FISH staining. (B) Due to
lack of specific human chromosome probes, these iciHHV-6B samples could
not be mapped to specific chromosomes. Red boxes highlight chromosomes
with integrated HHV-6, and yellow marks out dual-FISH-stained chromo-
somes. (Scale bars: main images, 10 μm; zoomed images, 2 μm.)
Fig. 4. Host−virus internal telomere from iciHHV-6 individuals. Detailed
views of the host−virus junction with the molecules spanning these regions
are shown for (A) ici6A-1 (KY315540) at 18q, (B) ici6B-3 (KY290178) at 18p,
(C) ici6B-1 (KY315552) at 19q, and (D) ici6B-2 (KY290184) at Xp. In gray text
are the median sizes from the host telomere repeats up to the virus genome.
Below the annotations are the individual dsDNA molecules that were used
to build the maps. Blue or red marks indicate DLE-I sites (marked with flu-
orophores in the samples), with the red marks not matching to the reference
genome. Black boxes mark out the end of the subtelomere region of the
host and the beginning of the telomeres in the GRCh38 human genome
annotation. Virus genome positions are annotated with green boxes
and lines.







































It could also be that the virus preferentially targets certain
chromosomal ends based on the length of their telomere.
The data also indicate that the telomeric repeat at the distal
end of the virus must then act as the chromosome’s telomere,
and has undergone extension to a length corresponding to
“normal” human telomeres. Human telomeres range in size from
8 kb to 15 kb (26, 27) and are maintained in germline cells by the
telomerase enzyme complex (35–39). Consistent with this, we
show that the distal telomeres of iciHHV-6 individuals are
around 10 kb. This suggests that the imperfect telomere repeats
on DR-L likely serve as a template for the formation of a neo-
telomere at the distal end. The telomerase complex could me-
diate this process, as it has recently been shown to contribute to
the integration process (40), but more work is required to fully
understand this pathway. Important to note is that the cells used
in this study were immortalized with Epstein−Barr virus (EBV),
which can induce telomerase activity (41). This suggests that the
length of the terminal telomeres measured in our experiments
rather reflects their length in telomerase positive cells in the
human body. Somatic cells in the human body do not exhibit
telomerase activity and could have overall shorter telomeres.
An essential function of the telomere is to disguise the chro-
mosome end from the DNA damage response, which is accom-
plished by the shelterin complex and self-hybridization of the
single-stranded telomere end into the upstream telomere re-
peats (42, 43). It is therefore interesting to speculate that per-
haps these internal telomere length differences between samples
may mirror these self-hybridization points of the telomere
overhang at the time HHV-6 integrated into the genome. A
deeper look at a larger number of iciHHV-6 junctions in com-
bination with analysis during the integration process is needed to
confirm whether this is the case.
Materials and Methods
Patient Cells and Culture. Samples used for this study were derived from
healthy stem cell donors (n = 3) and a patient with acute lymphoblastic
leukemia (KY290178) who were identified and described previously (16). The
donor with the X chromosome integration was a female. Peripheral blood
mononuclear cells (PBMCs) from iciHHV-6 individuals were immortalized
with EBV to obtain lymphoblastoid cell lines (B-LCLs). The B-LCLs were grown
to a concentration of ∼5 million cells per mL at 37 °C in Roswell Park Me-
morial Institute medium (RPMI) 1640 with L-glutamine culture medium
(Gibco) supplemented with 15% fetal bovine serum (Gibco/Invitrogen Corp)
and 1% 100 mM sodium pyruvate (Gibco). Cell lines were frozen in liquid
nitrogen until further use. Use of these samples was approved by the Fred
Hutchinson Cancer Research Center Institutional Review Board. The samples
were deidentified prior to use in this study.
FISH. FISH staining of the HHV-6 genome and/or cellular chromosomes was
performed using two specific set of probes: HHV-6 probes were labeled
using Biotin-High prime (Sigma Aldrich), and detection of the probe signal
Fig. 5. HHV-6−host junction and native telomere length. As iciHHV-6 is a heterozygous event, the optical maps also contain the reads obtained for the
terminal portion of the chromosome pair without HHV-6 integration. The telomere length of the chromosome without HHV-6 and the host−virus junction are
shown for (A) ici6A-1 at 18q and (B) ici6B-3 at 18p. Median size of the telomere ends for the chromosomes without a virus integration are shown in gray,
above the reference genome. Color scheme is the same as in Fig. 2.
Fig. 6. Distal telomeres of iciHHV-6 chromosomes. Molecules making up the
optical maps that cover the terminal parts of iciHHV-6 genomes are shown
for (A) ici6A-1 (KY315540), (B) ici6B-1 (KY315552), (C) ici6B-3 (KY290178),
and (D) ici6B-2 (KY290184). Median telomere length is shown for all external
HHV-6 telomeres in red text.































was achieved using Cy3-Streptavidin (1:200; Roche); chromosome-specific
probes were labeled using Digoxigenin-High prime (DIG-High prime)
(1:1,000; Sigma Aldrich), and probe signal was detected with anti-DIG fluo-
rescein isothiocyanate Fab fragments (GE healthcare). The FISH protocol was
performed as described previously (30, 44).
DNA Preparation. High molecular weight dsDNA was isolated from viable
human B-LCLs as outlined below. Cryopreserved cells were thawed in a 37 °C
water bath, and a volume containing 1.5 million cells was centrifuged at
2,000 × g for 2 min at 4 °C. Each cell pellet was washed in 500 μL of cold
Bionano DNA Stabilizing Buffer, containing 2% (vol/vol) DNA Stabilizer
(Bionano Genomics) in Cell Buffer (Bionano Genomics). The washed cells
were centrifuged a second time, as described above, and DNA extraction
was performed using an SP Blood & Cell DNA Isolation Kit (Bionano Geno-
mics), following the Prep SP Frozen Cell Pellet DNA Isolation Protocol. In
short, the washed cell pellets were resuspended in DNA Stabilizing Buffer
(Bionano Genomics) and lysed in the presence of detergents, proteinase K,
and RNase A. High molecular weight dsDNA was bound to a silica disk,
washed, and eluted.
Optical Molecule Generation. For each cell line, 750 ng of high molecular
weight dsDNA was fluorescently labeled using a Bionano Prep DNA Labeling
Kit-DLS according to the Prep Direct Label and Stain (DLS) Protocol. The
enzyme DLE-1 (Bionano Genomics) was used to fluorescently tag the motif
CTTAAG, and the dsDNA backbone was counterstained with DNA Stain
(Bionano Genomics). Targeting at least 480 Gbp of data per sample, high-
throughput imaging was performed using Bionano Genomics second-
generation Saphyr Systems and chips with Instrument Control Software
version 4.7.18339.1. Metadata regarding the optical molecules and align-
ments generated from these experiments can be found in Table 1.
Alignment of Molecules and Generation of Genome Maps. The HHV-6 genomes
were in silico digested with motif sequence CTTAAG of DLE-1 enzyme. To
detect the integration site of HHV-6, the labeled HHV-6 genomes were
concatenated with human hg38 genome and used as a reference genome
for subsequence analysis. The genome maps of each cell line were then
generated via haplotype-aware de novo assembly of single-molecule reads
with the following software suite: Bionano Access 1.4.3, Tools 1.4.3, Solve
3.4.1, and RefAligner 10026.10020rel. The HHV-6 integration sites were
identified by regions in the cell line genome maps that align to both human
hg38 genome and the viral genome maps.
Genetic Map Analysis. Genetic maps and aligned molecules were exported
from Bionano Access software (v1.5) as png image files. HHV-6 genomes were
annotated on the maps based on the distance to the last DLE-1 mark and the
known length in kilobases. Pixel length measurements were performed in
Fiji (ImageJ) and converted into kilobases using the measured scale. Median
lengths of all molecules measured are displayed in the manuscript to reduce
the influence of outlier measurements.
Data Availability. All study data are included in the article.
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